Centerpoint Advisors
ABBV icon

Centerpoint Advisors’s AbbVie ABBV Stock Holding History

Centerpoint Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$337K Buy
1,290
+108
+9% +$27.7K 0.09% 73
2026
Q2 		$297K Sell
1,182
-296
-20% -$63.7K 0.08% 74
2026
Q1 		$321K Sell
1,478
-297
-17% -$65.9K 0.1% 67
2025
Q4 		$405K Sell
1,775
-4
-0.2% -$911 0.12% 63
2025
Q3 		$412K Buy
1,779
+84
+5% +$17.1K 0.13% 64
2025
Q2 		$315K Buy
1,695
+12
+0.7% +$2.23K 0.11% 68
2025
Q1 		$353K Buy
1,683
+3
+0.2% +$583 0.13% 62
2024
Q4 		$298K Sell
1,680
-138
-8% -$25.4K 0.1% 71
2024
Q3 		$359K Sell
1,818
-96
-5% -$17.9K 0.12% 61
2024
Q2 		$328K Sell
1,914
-149
-7% -$24.7K 0.12% 65
2024
Q1 		$376K Buy
2,063
+328
+19% +$56.5K 0.14% 56
2023
Q4 		$269K Buy
1,735
+118
+7% +$17.2K 0.11% 71
2023
Q3 		$241K Buy
1,617
+4
+0.2% +$587 0.1% 81
2023
Q2 		$217K Sell
1,613
-134
-8% -$19.6K 0.09% 83
2023
Q1 		$278K Buy
1,747
+325
+23% +$49.7K 0.12% 74
2022
Q4 		$230K Buy
1,422
+11
+0.8% +$1.69K 0.11% 79
2022
Q3 		$189K Buy
1,411
+904
+178% +$130K 0.1% 80
2022
Q2 		$78K Buy
507
+113
+29% +$17.3K 0.04% 122
2022
Q1 		$64K Buy
394
+3
+0.8% +$436 0.03% 134
2021
Q4 		$53K Buy
391
+3
+0.8% +$354 0.02% 131
2021
Q3 		$42K Buy
388
+43
+12% +$4.91K 0.02% 134
2021
Q2 		$39K Buy
+345
New +$38.9K 0.02% 139
2018
Q4 		– Sell
-675
Closed -$64K – 250
2018
Q3 		$64K Buy
675
+570
+543% +$54.1K 0.05% 87
2018
Q2 		$10K Buy
105
+39
+59% +$3.81K 0.01% 176
2018
Q1 		$6K Buy
+66
New +$7.25K 0.01% 173

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Centerpoint Advisors's ABBV Position: Q3 2026 in Review

Centerpoint Advisors increased its AbbVie (ABBV) stake by 9.1% in Q3 2026, buying an estimated $27.7K and bringing the position to 1,290 shares worth $337K. The position accounts for 0.09% of the portfolio, ranked #73.

Centerpoint Advisors first reported a position in ABBV in Q1 2018 and has held it in 25 quarters since. The position peaked at $412K in Q3 2025. 2,975 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Centerpoint Advisors held 1,290 shares of AbbVie worth $337K as of Q3 2026.
  • Centerpoint Advisors bought 108 AbbVie shares in Q3 2026, an estimated $27.7K.
  • AbbVie made up 0.09% of Centerpoint Advisors's portfolio in Q3 2026, its #73 holding.
  • Centerpoint Advisors first reported a position in AbbVie in Q1 2018 and has held it in 25 quarters since.
  • Centerpoint Advisors's AbbVie position peaked at $412K in Q3 2025.
  • 2,975 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Centerpoint Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.